AI in Life Sciences Commercialization

Strategic insights and practical recommendations from 2025 survey of commercial leaders

Artificial intelligence (AI) is no longer experimental, it’s essential to commercial success in life sciences. In this new white paper, IQVIA shares findings from a 2025 survey of commercial leaders, revealing how organizations are moving from AI ambition to enterprise-scale execution.

Discover how companies are embedding AI across functions, achieving 2X–3X ROI, and overcoming barriers. With strategic insights and a practical playbook for scaling AI, this report is a must-read for leaders looking to turn innovation into impact.